Quest Diagnostics (DGX) Total Non-Current Liabilities (2009 - 2026)

Quest Diagnostics has reported Total Non-Current Liabilities for 18 years, with the latest figure at $15.9 billion in Q2 2026.

• Quarterly Total Non-Current Liabilities rose 5.31% year-over-year to $15.9 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $15.9 billion (up 5.31% YoY) and the FY2025 annual result came in at $15.3 billion, changed 0.35% from the prior year.
• Total Non-Current Liabilities improved to $15.9 billion in Q2 2026 per DGX's latest filing, from $15.7 billion in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $15.9 billion in Q2 2026 and troughed at $12.0 billion in Q1 2023.
• A 5-year average of $13.9 billion and a median of $13.6 billion in 2023 frame the typical range for Total Non-Current Liabilities.
• The sharpest annual moves came in 2022 and 2024: Total Non-Current Liabilities decreased 6.19% in 2022, then advanced 20.59% in 2024.
• Over 5 years, Total Non-Current Liabilities stood at $12.0 billion in 2022, then advanced by 9.32% to $13.1 billion in 2023, then gained by 15.74% to $15.2 billion in 2024, then advanced by 0.35% to $15.3 billion in 2025, then gained by 4.01% to $15.9 billion in 2026.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $15.9 billion, $15.7 billion, and $15.3 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.